J Korean Neurol Assoc.  2000 Jul;18(4):512-514.

A Case of Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine

Affiliations
  • 1Department of Neurology, Ajou University Hospital.
  • 2Department of Clinical Pathology, Ajou University Hospital.

Abstract

Ticlopidine, a widely used antiplatelet agent, has been rarely reported to cause thrombotic thrombocytopenic purpura (TTP). To the best of our knowledge, its occurrence has never before been reported in Korea. A 69 years old female patient suffered from an acute ischemic stroke. Ticlopidine 250mg bid was started and she followed an uneventful clin-ical course. The platelet count was normal on the 1st and the 12th day of ticlopidine administration. Around the 31st day, at home, she developed purpura, dyspnea and a stuporous mental status. Under the diagnosis of TTP, a plasma exchange was performed and her condition eventually returned to the baseline status. Ticlopidine induced TTP can developed abruptly despite close monitoring of platelet count, as illustrated by this case. Physicians prescribing ticlopi-dine should be aware of this potentially dangerous complication.

Keyword

Ticlopidine; Purpura/Thrombotic thrombocytopenic

MeSH Terms

Aged
Diagnosis
Dyspnea
Female
Humans
Korea
Plasma Exchange
Platelet Count
Purpura
Purpura, Thrombotic Thrombocytopenic*
Stroke
Stupor
Ticlopidine*
Ticlopidine
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr